{"nct_id":"NCT05132582","title":"A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-10","start_date":"2022-03-07","start_date_type":"ACTUAL","primary_completion_date":"2025-09-05","primary_completion_date_type":"ACTUAL","completion_date":"2027-09-28","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["PFE"]}